With a focus on patient-centric principles, CDI’s non-invasive and cost-effective portfolio of diagnostic products and solutions result in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. CDI operates out of our CLIA-certified laboratory and is a FDA registered, ISO 13485 certified medical device manufacturer.

At-Home Breath Testing Program from CDI

Benefits to Healthcare Providers and their Patients

CDI’s at-home breath test kits for SIBO, IMO, and carbohydrate malabsorption disorders help physicians obtain accurate results to inform diagnostic and treatment plans. Our functional GI diagnostic test kits not only help support meaningful GI health outcomes, but also are easy to use, quick, safe, and cost-effective for patients.

Fully Covered by Medicare with No Balance Billing

Third-Party Billing & Insurance Coverage on Most Tests

No Overhead Costs to Practices

No Restocking Fees or Hidden Costs

Direct-To-Patient or Direct-To-Practice Shipping

1 Business Day Turnaround Time for Results

Dedicated Customer Service and Patient Outreach

Result Interpretation Assistance

Non-Invasive At-Home Hydrogen and Methane Breath Testing

SIBO & IMO

Small Intestinal Bacterial Overgrowth (SIBO) and Intestinal Methanogen Overgrowth (IMO) are common causes of functional bloating, diarrhea, constipation and suspected malabsorption.

Learn More

Fructose
Malabsorption

Fructose intolerance is a condition in which absorption of fructose is impaired by deficient fructose carriers in the small intestine’s enterocytes.

Learn More

Lactose
Malabsorption

Lactose intolerance is the inability to digest the sugar lactose causing gastrointestinal symptoms such as flatulence, bloating, cramps, and diarrhea.

Learn More